Long-term observations of human immunodeficiency virus-infected chimpanzees.

Twenty-seven chimpanzees inoculated with material presumed to contain human immunodeficiency virus (HIV) between June 1983 and February 1985 were studied. The animals were examined on four to six occasions between 1989 and 1992 for serologic, virologic, hematologic, immunophenotypic, as well as clinical signs of HIV infection and compared to five uninfected control animals. The 19 animals that had seroconverted within 244 days of inoculation remained antibody positive, whereas those that did not seroconvert within 244 days of inoculation remained antibody negative 6 to 8 years later. HIV antigen was demonstrated at least once in lymphocyte cultures from 12 of the 19 antibody positive chimpanzees during this period. Nested polymerase chain reaction amplified proviral DNA in lymphocytes from 14 of the 19 animals. No proviral DNA was detected in antibody-negative animals. Antibody titers were generally higher in animals from which virus was recovered in lymphocyte cultures [granulocyte-macrophage (GM) titer, 1:8427] compared to virus-negative animals (GM titer, 1:3608). Mean total white blood cell and lymphocyte subtype counts were similar in the HIV-infected animals and uninfected controls. The high antibody levels and Western blot profiles, over periods as long as 9 years in these chimpanzees, suggest continuous stimulation of the immune system by HIV antigen although virus was detected only sporadically in the peripheral blood. No illness suggestive of immunodeficiency was seen.

[1]  R. B. Swenson,et al.  Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1. , 1991, The Journal of infectious diseases.

[2]  C. Debouck,et al.  Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Arthur,et al.  Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses , 1987, Journal of virology.

[4]  L. Epstein,et al.  IgG response to human immunodeficiency virus in experimentally infected chimpanzees mimics the IgG response in humans. , 1987, Journal of Infectious Diseases.

[5]  R. B. Swenson,et al.  Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome , 1986, Journal of virology.

[6]  H. Alter,et al.  Longitudinal Study of HTLV‐III‐Infected Chimpanzees by Lymphocyte Subpopulation Analysis , 1985, Journal of medical primatology.

[7]  L. Montagnier,et al.  INFECTION OF CHIMPANZEES BY HUMAN T-LYMPHOTROPIC RETROVIRUSES IN BRAIN AND OTHER TISSUES FROM AIDS PATIENTS , 1985, The Lancet.

[8]  W. Saxinger,et al.  Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. , 1984, Science.

[9]  P. Nara,et al.  The Biology of Human Immunodeficiency Virus‐1 IIIB Infection in the Chimpanzee: In Vivo and In Vitro Correlations , 1989, Journal of medical primatology.

[10]  J. Chermann,et al.  A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: Structural and antigenic relatedness with equine infectious anaemia virus , 1984 .